Ultrasound measurements of subcutaneous adipose tissue in infants are reproducible

Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance

CONTEXT

Nonalcoholic fatty liver disease (NAFLD) is known to have a gender-dimorphic prevalence in obese children. Less information is available on predictive factors for NAFLD in obese youths.

OBJECTIVE

The aim of the study was to examine the prevalence pattern and to identify clinical and laboratory markers associated with the risk for NAFLD.

DESIGN

This was a cross-sectional study.

SETTING

The study setting was a rehabilitation clinic.

STUDY PARTICIPANTS

A total of 532 obese subjects (291 girls) aged 8-19 yr participated in the study.

MAIN MEASUREMENTS

Steatosis hepatis and visceral fat mass were determined by ultrasound. Laboratory tests included serum lipids, adiponectin, high-sensitivity C-reactive protein, sex steroids, and an oral glucose tolerance test.

RESULTS

Prevalence of hepatic steatosis was significantly higher in boys (41.1%) than in girls (17.2%) and was highest in postpubertal boys (51.2%) and lowest in postpubertal girls (12.2%). Severity of steatosis was associated with increased visceral fat mass, insulin resistance, lower adiponectin levels, and higher blood pressure. Three factors were extracted from the panel of investigated parameters by principal component analysis. Logistic regression analysis revealed significant associations of simple steatosis with the "insulin resistance and visceral fat" factor and the "body fat distribution and inflammation" factor in both genders and additionally with the "steroid hormones" factor in girls. Risk for steatosis hepatis with concomitantly elevated ALT was associated only with "insulin resistance and visceral fat" in girls and with all three factors in boys.

CONCLUSION

Our results suggest significant associations of NAFLD with markers of visceral obesity and insulin resistance in both genders and gender-specific associations with parameters of body fat distribution and sex steroids.

Fetal upper arm volume in predicting intrauterine growth restriction: a three-dimensional ultrasound study

As fetuses with intrauterine growth restriction (IUGR) may have increased risks with perinatal morbidity and mortality, prenatal diagnosis of IUGR is a very important issue in perinatology. To assess the efficacy of fetal upper arm volume in predicting IUGR, we undertook a prospective, cross-sectional study using quantitative three-dimensional (3D) ultrasound (US). In total, 40 fetuses with IUGR and 442 fetuses without IUGR were included for the upper arm volume assessment in utero by 3D US. All the fetuses were singletons and were followed up to delivery to establish whether they were complicated with IUGR or not. Our results showed that fetal upper arm volume assessed by 3D US can differentiate fetuses with IUGR from fetuses without IUGR well. The best predicting threshold for IUGR is at the 10th percentile by upper arm volume. Using the 10th percentile as the cutoff, the sensitivity of fetal upper arm volume in predicting IUGR was 97.5%, with specificity 92.8%, predictive value of positive test 54.9%, predictive value of negative test 99.8% and accuracy 93.1%. Furthermore, upper arm volume is the best parameter for detecting IUGR among the common fetal biometric indices, such as biparietal diameter (BPD), occipitofrontal diameter (OFD), head circumference (HC), abdominal circumference (AC), femur length (FL) and estimated fetal weight (EFW). In conclusion, fetal upper arm volume assessed by quantitative 3D US can be used to predict fetuses with IUGR antenatally. We believe fetal upper arm volume assessment by 3D US would be a useful test in detecting fetuses with IUGR.

Body composition measurements during infancy

Infancy is the period of most rapid postnatal growth and is accompanied by major changes in body composition (BC). There are many challenges to successfully measuring BC of infants in vivo, which include the inherent limitations in the underlying assumptions for each technique. The small body mass and rapid nonuniform changes in body parts, that is, the components of BC during infancy, can strain the technical limits of all methods. Many techniques for in vivo BC measurement used in older people have been applied to infants. However, the vast majority of them either are difficult to adapt for widespread use in infants, or the roles and limitations for using them during infancy are ill-defined because of limited or no critical validation and cross-calibration studies. Based on validation data from animals, well-defined methodological issues in data acquisition and analyses, availability of normative data, and pertinent accuracy and precision of the technique to allow us to determinate clinically relevant changes in BC within a reasonable time interval, three techniques appear to be most suitable for in vivo BC measurement in infants. Anthropometric measurements can be used in field studies or for group comparisons, and total body electrical conductivity (TOBEC) and selected dual-energy X-ray absorptiometry (DXA) measurements can be used to compare BC in individual infants. DXA has the advantages of being able to measure bone mass and the potential to be adaptable to the widely available existing instruments. However, regardless of the techniques used in measuring BC in infants, meticulous attention to details in data acquisition and data analysis, and a knowledge of the limitations of the particular technique are the prerequisites for generating valid data.